• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Sacubitril/Valsartan, Heart Failure and Risk of Dementia.

作者信息

Garnier-Crussard Antoine, Dauphinot Virginie, Mouchoux Christelle, Novais Teddy

机构信息

University Lyon 1, Lyon, France.

Clinical and Research Memory Centre of Lyon, Department of Geriatric Medicine, Charpennes Hospital, Lyon Institute for Aging, Hospices Civils de Lyon, 27 rue Gabriel Péri, 69100, Villeurbanne, France.

出版信息

Drugs Aging. 2025 Sep 16. doi: 10.1007/s40266-025-01242-0.

DOI:10.1007/s40266-025-01242-0
PMID:40958062
Abstract
摘要

相似文献

1
Sacubitril/Valsartan, Heart Failure and Risk of Dementia.沙库巴曲缬沙坦、心力衰竭与痴呆风险
Drugs Aging. 2025 Sep 16. doi: 10.1007/s40266-025-01242-0.
2
Association between sacubitril/valsartan and risk of dementia in patients with heart failure: a nationwide cohort study.沙库巴曲缬沙坦与心力衰竭患者痴呆风险的关联：一项全国性队列研究。
Eur Heart J Cardiovasc Pharmacother. 2025 Aug 12;11(5):412-421. doi: 10.1093/ehjcvp/pvaf024.
3
Sacubitril/Valsartan Reduces the Risk of All-Cause Dementia in Patients with Heart Failure: A Systematic Review and Meta-Analysis.沙库巴曲缬沙坦降低心力衰竭患者全因性痴呆风险：一项系统评价与荟萃分析
Drugs Aging. 2025 Jul 29. doi: 10.1007/s40266-025-01233-1.
4
Efficacy and safety of sacubitril/valsartan in end-stage renal disease patients with heart failure: a review.沙库巴曲缬沙坦在终末期肾病合并心力衰竭患者中的疗效与安全性：一项综述
Ann Med. 2025 Dec;57(1):2557515. doi: 10.1080/07853890.2025.2557515. Epub 2025 Sep 8.
5
The role of sacubitril/valsartan in abnormal renal function patients combined with heart failure: a meta-analysis and systematic analysis.沙库巴曲缬沙坦在肾功能异常合并心力衰竭患者中的作用：一项荟萃分析与系统分析
Ren Fail. 2024 Dec;46(1):2349135. doi: 10.1080/0886022X.2024.2349135. Epub 2024 Jun 13.
6
Comprehensive Analysis of the Effects of Sacubitril/Valsartan According to Sex Among Patients With Heart Failure and Reduced Ejection Fraction in PARADIGM-HF.PARADIGM-HF研究中射血分数降低的心力衰竭患者按性别对沙库巴曲缬沙坦效果的综合分析
J Am Heart Assoc. 2025 May 6;14(9):e038249. doi: 10.1161/JAHA.124.038249. Epub 2025 Apr 23.
7
Effects and Safety of Sacubitril/Valsartan for Patients with Myocardial Infarction: A Systematic Review and Meta-Analysis.沙库巴曲缬沙坦治疗心肌梗死患者的效果及安全性：系统评价和荟萃分析。
J Healthc Eng. 2022 Jan 5;2022:7840852. doi: 10.1155/2022/7840852. eCollection 2022.
8
Cost-Utility Analysis of Sacubitril/Valsartan Use Compared With Standard Care in Chronic Heart Failure Patients With Reduced Ejection Fraction in South Korea.韩国射血分数降低的慢性心力衰竭患者中沙库巴曲缬沙坦与标准治疗相比的成本-效用分析。
Clin Ther. 2019 Jun;41(6):1066-1079. doi: 10.1016/j.clinthera.2019.04.031. Epub 2019 May 15.
9
Relative Efficacy of Sacubitril-Valsartan, Vericiguat, and SGLT2 Inhibitors in Heart Failure with Reduced Ejection Fraction: a Systematic Review and Network Meta-Analysis.沙库巴曲缬沙坦、维立西呱和 SGLT2 抑制剂在射血分数降低的心力衰竭中的相对疗效：系统评价和网络荟萃分析。
Cardiovasc Drugs Ther. 2021 Oct;35(5):1067-1076. doi: 10.1007/s10557-020-07099-2. Epub 2020 Oct 19.
10
Effects of Sacubitril/Valsartan on All-Cause Hospitalizations in Heart Failure: Post Hoc Analysis of the PARADIGM-HF and PARAGON-HF Randomized Clinical Trials.沙库巴曲缬沙坦对心力衰竭患者全因住院的影响：PARADIGM-HF 和 PARAGON-HF 随机临床试验的事后分析。
JAMA Cardiol. 2024 Nov 1;9(11):1047-1052. doi: 10.1001/jamacardio.2024.2566.

本文引用的文献

1
Sacubitril/Valsartan Reduces the Risk of All-Cause Dementia in Patients with Heart Failure: A Systematic Review and Meta-Analysis.沙库巴曲缬沙坦降低心力衰竭患者全因性痴呆风险：一项系统评价与荟萃分析
Drugs Aging. 2025 Jul 29. doi: 10.1007/s40266-025-01233-1.
2
Association between self-reported multimorbidity and longitudinal brain Aβ deposition in Alzheimer's disease.自我报告的多种疾病与阿尔茨海默病中脑内β淀粉样蛋白的纵向沉积之间的关联。
Nat Commun. 2025 Jul 1;16(1):5905. doi: 10.1038/s41467-025-60748-8.
3
Blood pressure reduction and all-cause dementia in people with uncontrolled hypertension: an open-label, blinded-endpoint, cluster-randomized trial.
血压降低与未控制高血压患者的全因性痴呆：一项开放标签、盲终点、整群随机试验。
Nat Med. 2025 Apr 21. doi: 10.1038/s41591-025-03616-8.
4
Cardioprotective Glucose-Lowering Agents and Dementia Risk: A Systematic Review and Meta-Analysis.具有心脏保护作用的降糖药物与痴呆风险：一项系统评价和荟萃分析
JAMA Neurol. 2025 May 1;82(5):450-460. doi: 10.1001/jamaneurol.2025.0360.
5
Impact of heart failure medications on cognitive function: A systematic review.心力衰竭药物对认知功能的影响：一项系统综述。
Eur J Clin Invest. 2025 Jul;55(7):e70008. doi: 10.1111/eci.70008. Epub 2025 Feb 10.
6
Use of common cardiovascular disease drugs and risk of dementia: A case-control study in Swedish national register data.常用心血管疾病药物的使用与痴呆风险：基于瑞典国家登记数据的病例对照研究
Alzheimers Dement. 2025 Jan;21(1):e14389. doi: 10.1002/alz.14389. Epub 2024 Nov 18.
7
Differences in Pharmacological Treatment of Heart Failure Among Persons with or without Major Cognitive Disorder: A Cross-Sectional Study Based on National Registries in Sweden.心力衰竭伴或不伴主要认知障碍患者药物治疗的差异：基于瑞典国家登记处的横断面研究。
Drugs Aging. 2024 Nov;41(11):907-913. doi: 10.1007/s40266-024-01153-6. Epub 2024 Nov 3.
8
Trajectory of Cognitive Decline After Incident Heart Failure Hospitalization: Findings From the REGARDS Study.事件性心力衰竭住院后认知能力下降轨迹：来自 REGARDS 研究的结果。
J Am Heart Assoc. 2024 Sep 3;13(17):e032986. doi: 10.1161/JAHA.123.032986. Epub 2024 Aug 29.
9
Risk of dementia after initiation of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in adults aged 40-69 years with type 2 diabetes: population based cohort study.40-69 岁 2 型糖尿病成人中钠-葡萄糖共转运蛋白 2 抑制剂与二肽基肽酶-4 抑制剂起始治疗后痴呆风险的比较：基于人群的队列研究。
BMJ. 2024 Aug 28;386:e079475. doi: 10.1136/bmj-2024-079475.
10
Association between treatment with sacubitril/valsartan and the risk of Alzheimer's disease: a clinical update.沙库巴曲缬沙坦与阿尔茨海默病风险的相关性：临床更新。
Alzheimers Res Ther. 2024 Aug 1;16(1):177. doi: 10.1186/s13195-024-01547-z.